Corcept Therapeutics competitive analysis

Explore Corcept Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 17, 2026
Patent NumberPublication DateTitleTotal Oppositions
Dec 3, 2025Pharmaceutical Formulations Containing Relacorilant, A Heteroaryl-Ketone Fused Azadecalin Compound1

Latest PTAB cases involving Corcept Therapeutics

Discover the latest PTAB cases involving Corcept Therapeutics, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 17, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Corcept Therapeutics

PGR2019-00048May 7, 2019TEVA PHARMACEUTICALSCORCEPT THERAPEUTICSFinal Written Decision
IPR2018-01494Aug 2, 2018NEPTUNE GENERICSCORCEPT THERAPEUTICSFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Corcept Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CORCEPT THERAPEUTICS - - - 2
NEPTUNE GENERICS - - 6 -
TEVA PHARMACEUTICALS5191712